[Diagnosis and treatment of infectious pharyngeal inflammation].
Symptoms of viral and/or streptococcal infectious pharyngitis are of interest in the context of different therapeutic strategies. This study involved 3 family medicine clinics, one emergency service department, and 694 patients. Streptococcal pharyngitis occurred in 24% of the adult patients and in 29% of all the patients. The remaining ones had acute viral pharyngitis or a mixed viral/bacterial infection. Medicamentous therapy given to 98% of the patients included local antibiotics (42%), systemic antibacterial monotherapy (12%), and combined antibiotic therapy (44%). Lysozime-containing preparations (larypront, dequalar, etc.) recommended for pathogenetic therapy had the active ingredient in the form of a dequalinium complex to deliver lysozime to pharyngeal mucosa. The frequency of streptococcal infection in patients with secondary sore throat receiving the combined treatment was twice lower (12%) than in the general group. The strategy of therapy was the same as in primary sore throat.